Precision Optics Corporation, Inc. (POCI)
NASDAQ: POCI · IEX Real-Time Price · USD
5.98
-0.04 (-0.66%)
At close: Jul 19, 2024, 4:30 PM
5.94
-0.04 (-0.67%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Company Description
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area.
It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.
The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies.
The company was incorporated in 1982 and is based in Gardner, Massachusetts.
Precision Optics Corporation, Inc.
| Country | United States |
| Founded | 1982 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 85 |
| CEO | Dr. Joseph N. Forkey |
Contact Details
Address: 22 East Broadway Gardner, Massachusetts 01440 United States | |
| Phone | 978-630-1800 |
| Website | poci.com |
Stock Details
| Ticker Symbol | POCI |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000867840 |
| CUSIP Number | 740294400 |
| ISIN Number | US7402944000 |
| Employer ID | 04-2795294 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Richard E. Forkey | Founder, Advisor to the Chief Executive Officer and Director Emeritus |
| Dr. Joseph N. Forkey | Chief Executive Officer, President, Treasurer and Director |
| Jeffrey L. DiRubio | Executive Vice President of Sales and Marketing |
| Wayne M. Coll | Chief Financial Officer and Secretary |
| Mahesh Lawande | Chief Operating Officer |
| Bruce Radl | Director of Technology Development |
| Divaker Mangadu | President of Ross Optical Division |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 3, 2024 | 8-K | Current Report |
| Jun 14, 2024 | EFFECT | Notice of Effectiveness |
| Jun 11, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Jun 11, 2024 | UPLOAD | Filing |
| Jun 7, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| May 17, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| May 15, 2024 | 10-Q | Quarterly Report |
| Mar 1, 2024 | UPLOAD | Filing |
| Feb 28, 2024 | 10-K/A | [Amend] Annual report |
| Feb 14, 2024 | 10-Q | Quarterly Report |